In recent years, radiolabeled quinoline-based FAP inhibitors (FAPIs) have been developed as a PET radiotracer targeting FAP-expressing cells, inaugurating a new era in molecular imaging, especially for tumor imaging [131,132]. The gene discussed is FAP; the disease is neoplasm.